Differentiating Hypoglycemia from other diseases: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(34 intermediate revisions by 5 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Hypoglycemia}}
[[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/Hypoglycemia]]
{{CMG}}
{{CMG}}; {{AE}} {{MAD}}


==Overview==
==Overview==
Hypoglycemia should be differentiated from other causes of [[autonomic]] hyperactivity symptoms. Neonatal hypoglycemia should be differentiated from other causes of neurological symptoms in neonates such as [[sepsis]], metabolic diseases: [[urea cycle disorders]], and branched-chain organic acidemias, [[hyponatremia]] and [[Asphyxia|neonatal asphyxia]]. In adults, hypoglycemia should be differentiated from other diseases that may cause autonomic hyperactivity symptoms, such as [[hyperthyroidism]], [[anxiety]], [[Cardiac arrhythmia|arrhythmia]], and [[pheochromocytoma]].


==Differentiating Hypoglycemia from other Diseases==
==Differentiating Hypoglycemia from other Diseases==
Neonatal hypoglycemia should be differentiated from other causes of neurological symtpoms in neonates:  
==== Differentiating Different Causes of Hypoglycemia from each other: ====
{| class="wikitable"
{| class="wikitable"
!Disease
!
!
!
!
!Fasting symptoms
!Postprandial symptoms
!Plasma [[insulin]]
![[C-peptide]]
![[proinsulin]]
![[Sulfonylurea]] in plasma
!insulin or insulin receptor antibodies
|-
|[[Insulinoma]]
| +
| -
|high
|high
|high
| -
| -
|-
|Oral hypoglycemia agent-induced
| -
| -
|high
|high
|high
| +
| -
|-
|Autoimmune hypoglycemia
| -
| -
|high
|high
|high
| -
| +
|-
|NIPHS*
| -
| +
|high
|high
|high
| -
| -
|-
|Exogenous [[insulin]]
| -
| -
|high
|low
|low
| -
| -
|-
|Non-islet cell tumors
| -
| -
|low
|low
|low
| -
| -
|}
<nowiki>*</nowiki>(NIPHS) non-insulinoma pancreatogenous hypoglycemia syndrome
*'''Differentials for [[Hypoglycemia]] on the basis of Laboratory findings:'''<ref name="pmid19088155">{{cite journal| author=Cryer PE, Axelrod L, Grossman AB, Heller SR, Montori VM, Seaquist ER et al.| title=Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. | journal=J Clin Endocrinol Metab | year= 2009 | volume= 94 | issue= 3 | pages= 709-28 | pmid=19088155 | doi=10.1210/jc.2008-1410 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19088155  }} </ref>
{| class="sortable"
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
! rowspan="2" |Diagnoses
! colspan="8" |Laboratory Findings differentiating among causes of Hypoglycemia
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
!S.Glucose<br>(mg/dL)
!C Peptide (pmol/L)
!S.Insulin (μU/mL)
!S.Proinsulin<br>(pmol/L)
!S. Beta hydroxybutyrate
!Glucose increase after glucagon(mg/dL)
!Oral Hypoglycemic agent
!Antibodies to Insulin
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Normal/Fasting
| style="background: #F5F5F5; padding: 5px;text-align: center;" |<55
| style="background: #F5F5F5; padding: 5px;text-align: center;" |<200
| style="background: #F5F5F5; padding: 5px;text-align: center;" |<3
| style="background: #F5F5F5; padding: 5px;text-align: center;" |<5
| style="background: #F5F5F5; padding: 5px;text-align: center;" |>2.7
| style="background: #F5F5F5; padding: 5px;text-align: center;" |<25
| style="background: #F5F5F5; padding: 5px;text-align: center;" | -
| style="background: #F5F5F5; padding: 5px;text-align: center;" | -
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Exogenous Insulin
| style="background: #F5F5F5; padding: 5px;text-align: center;" |<55
| style="background: #F5F5F5; padding: 5px;text-align: center;" |<200
| style="background: #F5F5F5; padding: 5px;text-align: center;" |>>3
| style="background: #F5F5F5; padding: 5px;text-align: center;" |<5
| style="background: #F5F5F5; padding: 5px;text-align: center;" |≤2.7
| style="background: #F5F5F5; padding: 5px;text-align: center;" |>25
| style="background: #F5F5F5; padding: 5px;text-align: center;" | -
| style="background: #F5F5F5; padding: 5px;text-align: center;" | -
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Insulinoma]]
| rowspan="3" style="background: #F5F5F5; padding: 5px;text-align: center;" |<55
| rowspan="3" style="background: #F5F5F5; padding: 5px;text-align: center;" |≥200
| rowspan="3" style="background: #F5F5F5; padding: 5px;text-align: center;" |≥3
| rowspan="3" style="background: #F5F5F5; padding: 5px;text-align: center;" |≥5
| rowspan="3" style="background: #F5F5F5; padding: 5px;text-align: center;" |≤2.7
| rowspan="3" style="background: #F5F5F5; padding: 5px;text-align: center;" |>25
| rowspan="3" style="background: #F5F5F5; padding: 5px;text-align: center;" | -
| rowspan="3" style="background: #F5F5F5; padding: 5px;text-align: center;" | -
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Nesidioblastosis]]
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Post gastric bypass hypoglycemia (PGPH)
|-
| style="background: #DCDCDC; padding: 5px;text-align: center;" |Insulin autoimmune hypoglycemia
| style="background: #F5F5F5; padding: 5px;text-align: center;" |<55
| style="background: #F5F5F5; padding: 5px;text-align: center;" |>>200<sup>‡</sup>
| style="background: #F5F5F5; padding: 5px;text-align: center;" |>>3
| style="background: #F5F5F5; padding: 5px;text-align: center;" |>>5<sup>‡</sup>
| style="background: #F5F5F5; padding: 5px;text-align: center;" |≤2.7
| style="background: #F5F5F5; padding: 5px;text-align: center;" |>25
| style="background: #F5F5F5; padding: 5px;text-align: center;" | -
| style="background: #F5F5F5; padding: 5px;text-align: center;" | +
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Oral hypoglycemic agent]]
| style="background: #F5F5F5; padding: 5px;text-align: center;" |<55
| style="background: #F5F5F5; padding: 5px;text-align: center;" |≥200
| style="background: #F5F5F5; padding: 5px;text-align: center;" |S.
| style="background: #F5F5F5; padding: 5px;text-align: center;" |≥5
| style="background: #F5F5F5; padding: 5px;text-align: center;" |≤2.7
| style="background: #F5F5F5; padding: 5px;text-align: center;" |>25
| style="background: #F5F5F5; padding: 5px;text-align: center;" | +
| style="background: #F5F5F5; padding: 5px;text-align: center;" | -
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[IGF]]¤
| style="background: #F5F5F5; padding: 5px;text-align: center;" |<55
| style="background: #F5F5F5; padding: 5px;text-align: center;" |<200
| style="background: #F5F5F5; padding: 5px;text-align: center;" |<3
| style="background: #F5F5F5; padding: 5px;text-align: center;" |<5
| style="background: #F5F5F5; padding: 5px;text-align: center;" |≤2.7
| style="background: #F5F5F5; padding: 5px;text-align: center;" |>25
| style="background: #F5F5F5; padding: 5px;text-align: center;" | -
| style="background: #F5F5F5; padding: 5px;text-align: center;" | -
|-
| colspan="9" style="background: #DCDCDC; padding: 5px; " |
‡ Free C-peptide and proinsulin concentrations are low<br>
¤ [[IGF]]= Insulin Growth Factor, Increased pro-IGF-2, free [[Insulin-like growth factor 2|IGF]]-2, IGF-2/[[IGF-1]] ratio
|}
==== Differentiating Hypoglycemia from other diseases that cause autonomic hyperactivity symptoms: ====
{| class="wikitable"
! rowspan="3" style="background: #4479BA; color: #FFFFFF; " |Disease
! colspan="5" style="background: #4479BA; color: #FFFFFF; " |Clinical Manifestation
! rowspan="3" style="background: #4479BA; color: #FFFFFF; " |Investigations
|-
! colspan="4" style="background: #4479BA; color: #FFFFFF; " |Symptoms
! rowspan="2" style="background: #4479BA; color: #FFFFFF; " |Signs
|-
! style="background: #4479BA; color: #FFFFFF; " |Palpitations
! style="background: #4479BA; color: #FFFFFF; " |Fever
! style="background: #4479BA; color: #FFFFFF; " |Sweating
! style="background: #4479BA; color: #FFFFFF; " |Headache
|-
|-
|Sepsis
![[Hypoglycemia]]
| +
| -
| +
| +
|
* [[Tachycardia]]
* Blurred vision
* [[Pallor]]
* [[Tremor|Tremors]]
* [[Seizures]]/ [[Coma]]
|
|
* Plasma [[glucose]] <70 mg/dL
* Serum [[Insulin]] level
* Serum [[Proinsulin]]
* Serum [[C-peptide|C-Peptide]]
|-
![[Anxiety disorders]]
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|
|
* Patient looks [[irritable]]
* Rapid [[pulse]] and may be irregular
|
|
* Psychiatry evaluation
|-
|-
|Inborn errors of metabolism
![[Pheochromocytoma]]<ref name="pmid11903030">{{cite journal| author=Lenders JW, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P et al.| title=Biochemical diagnosis of pheochromocytoma: which test is best? | journal=JAMA | year= 2002 | volume= 287 | issue= 11 | pages= 1427-34 | pmid=11903030 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11903030  }}</ref><ref name="pmid1787652">{{cite journal| author=Bravo EL| title=Pheochromocytoma: new concepts and future trends. | journal=Kidney Int | year= 1991 | volume= 40 | issue= 3 | pages= 544-56 | pmid=1787652 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1787652  }}</ref>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|
* [[Tachycardia]]
 
* Strong rapid [[pulse]]
 
* High [[pulse pressure]]
|
|
* Plasma fractionated [[Metanephrine|metanephrines]], 24-hour urinary fractionated [[Metanephrine|metanephrines]], [[catecholamines]].
* [[Computed tomography]]: Radiological evaluation should follow lab tests to locate site of the [[tumor]]<nowiki/>r.
|-
![[Arrhythmias|Arrhythmia]]
| +
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|
|
* Irregular pulse
|
|
* ECG changes according to the cause
|-
|-
|Hyponatremia
![[Hyperthyroidism]]
| +
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|
|
* Hyperactive [[Deep tendon reflex|deep tendon reflexes]]
* [[Thyromegaly]]
* [[Exophthalmus]]
|
|
* Level of [[thyroid-stimulating hormone]] ([[TSH]])
* Levels of T4 and/or T3 in the blood
* [[Antibody|Antibodies]] such as anti-[[TSH receptor|TSH-receptor antibodies]] in [[Graves' disease]]
|}
==== Differentiating Hypoglycemia from other Diseases that Cause Neurological Symptoms in Neonates: ====
{| class="wikitable"
! rowspan="2" |Disease
! colspan="5" |History and symptoms
! rowspan="2" |Investigations
|-
!Family History
!Lethargy and irritability
!Improvement of symptoms with glucose intake
!Fever
![[Hepatomegaly]]
|-
|[[Hypoglycemia]]
| +
| +
| +
| -
| -
|
|
* Blood glucose level
|-
|-
|perinatal asphyxia
|[[Sepsis]]
| -
|            <nowiki>+</nowiki>
|                                <nowiki>-</nowiki>
| +
|        <nowiki>-</nowiki>
|
|
* Blood cultures
|-
|[[Inborn error of metabolism|Inborn errors of metabolism]]
|            <nowiki>+</nowiki>
|            <nowiki>+</nowiki>
|                                <nowiki>-</nowiki>
| -
|        <nowiki>+</nowiki>
|
|
* Positive blood tests
|-
|[[Hyponatremia]]
| -
|            <nowiki>+</nowiki>
|                                <nowiki>-</nowiki>
| -
|        <nowiki>-</nowiki>
|
|
* Plasma sodium falls below 125 mEq/L
|-
|[[Perinatal asphyxia]]
|      <nowiki>+</nowiki>
|            <nowiki>+</nowiki>
| -
| -
|        <nowiki>-</nowiki>
|
* MRI of acute brain injury confirms the diagnosis of encephalopathy
|}
|}


In neonates, nonspecific signs of sepsis are often similar to those of hypoglycemia, such as irritability, lethargy, and tachypnea.
====Differentiating Hypoglycemia from other Diseases that Cause Coma and Consciousness Alterations: ====
 
Because of the serious consequences,
 
empiric antibiotic therapy should be provided (after cultures are obtained) to infants with suspected sepsis pending definitive culture-based diagnosis, in addition to administrating interventions directed towards hypoglycemia.
 
Metabolic diseases that often present between 12 and 72 hours of age after the initiation of oral feeding include hyperglycinemia, urea cycle disorders, and branched-chain organic acidemias. Hypoglycemia may also be an associated finding in patients with some metabolic diseases (table 1) and will persist despite measures to increase blood glucose levels. The diagnosis of inborn errors of metabolism and specific disorders is discussed separately.
 
Patients typically are not symptomatic until serum or plasma sodium falls below 125 mEq/L, and present with neurologic manifestations including lethargy, obtundation, and, eventually, seizures. The diagnosis of hyponatremia is made by obtaining serum electrolyte levels
 
Neonatal encephalopathy can present with lethargy and irritability, but symptoms fail to improve with an increase in blood glucose levels. Evidence by magnetic resonance imaging of acute brain injury confirms the diagnosis of encephalopathy. 
{|
{|
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
! rowspan="2" |<small>Diseases</small>
! rowspan="2" |<small>Diseases</small>
! colspan="4" |<small>Diagnostic tests</small>
! colspan="3" |<small>Diagnostic tests</small>
! colspan="5" |<small>Physical Examination</small>
! colspan="5" |<small>Physical Examination</small>
! colspan="3" |<small>Symptoms
! colspan="3" |<small>Symptoms
Line 54: Line 310:
! rowspan="2" |<small>Other Findings</small>
! rowspan="2" |<small>Other Findings</small>
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
!<small>Na+, K+, Ca2+</small>
!<small>CT /MRI</small>
!<small>CT /MRI</small>
!<small>CSF Findings</small>
!<small>CSF Findings</small>
Line 67: Line 322:
!<small>Altered mental status</small>
!<small>Altered mental status</small>
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" | [[Brain tumour]]<ref name="pmid1278192">Soffer D (1976) [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=1278192 Brain tumors simulating purulent meningitis.] ''Eur Neurol'' 14 (3):192-7. PMID: [http://pubmed.gov/1278192 1278192]</ref><ref name="pmid3883130" />
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hypoglycemia]]  
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |Serum blood [[Glucose-1-phosphate adenylyltransferase|glucose]]
[[HbA1c]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;text-align:center" |
| style="background: #F5F5F5; padding: 5px;text-align:center" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px; text-align:center" |  ✔
| style="background: #F5F5F5; padding: 5px; text-align:center" |
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |History of [[Diabetes mellitus|diabetes]]
| style="background: #F5F5F5; padding: 5px;" |[[Palpitation|Palpitations]], [[sweating]], [[dizziness]], low serum, [[glucose]]
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" | [[Brain tumour|Brain tumor]]<ref name="pmid1278192">Soffer D (1976) [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=1278192 Brain tumors simulating purulent meningitis.] ''Eur Neurol'' 14 (3):192-7. PMID: [http://pubmed.gov/1278192 1278192]</ref><ref name="pmid3883130" />
| style="background: #F5F5F5; padding: 5px; text-align:center" |✔
| style="background: #F5F5F5; padding: 5px; text-align:center" |✔
| style="background: #F5F5F5; padding: 5px text-align:center" |Cancer cells<ref name="pmid21371327">{{cite journal| author=Weston CL, Glantz MJ, Connor JR| title=Detection of cancer cells in the cerebrospinal fluid: current methods and future directions. | journal=Fluids Barriers CNS | year= 2011 | volume= 8 | issue= 1 | pages= 14 | pmid=21371327 | doi=10.1186/2045-8118-8-14 | pmc=3059292 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21371327  }}</ref>
| style="background: #F5F5F5; padding: 5px text-align:center" |[[Cancer]] cells<ref name="pmid21371327">{{cite journal| author=Weston CL, Glantz MJ, Connor JR| title=Detection of cancer cells in the cerebrospinal fluid: current methods and future directions. | journal=Fluids Barriers CNS | year= 2011 | volume= 8 | issue= 1 | pages= 14 | pmid=21371327 | doi=10.1186/2045-8118-8-14 | pmc=3059292 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21371327  }}</ref>
| style="background: #F5F5F5; padding: 5px;" |MRI  
| style="background: #F5F5F5; padding: 5px;" |MRI  
| style="background: #F5F5F5; padding: 5px; text-align:center" |       
| style="background: #F5F5F5; padding: 5px; text-align:center" |       
Line 84: Line 354:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Delirium tremens]]
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Delirium tremens]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px; text-align:center" |✔
| style="background: #F5F5F5; padding: 5px; text-align:center" |✔
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 96: Line 365:
| style="background: #F5F5F5; padding: 5px; text-align:center" |✔
| style="background: #F5F5F5; padding: 5px; text-align:center" |✔
| style="background: #F5F5F5; padding: 5px; text-align:center" |✔
| style="background: #F5F5F5; padding: 5px; text-align:center" |✔
| style="background: #F5F5F5; padding: 5px;" |[[Alcohol]] intake, sudden witdrawl or reduction in consumption  
| style="background: #F5F5F5; padding: 5px;" |[[Alcohol]] intake, sudden withdrawal or reduction in consumption  
| style="background: #F5F5F5; padding: 5px;" |[[Tachycardia]], [[diaphoresis]], [[hypertension]], [[tremors]], [[mydriasis]], [[positional nystagmus]],  
| style="background: #F5F5F5; padding: 5px;" |[[Tachycardia]], [[diaphoresis]], [[hypertension]], [[tremors]], [[mydriasis]], [[positional nystagmus]],  
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" | [[Subarachnoid hemorrhage|Subarachnoid  hemorrhage]]<ref name="pmid14585453">Yeh ST, Lee WJ, Lin HJ, Chen CY, Te AL, Lin HJ (2003) [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=14585453 Nonaneurysmal subarachnoid hemorrhage secondary to tuberculous meningitis: report of two cases.] ''J Emerg Med'' 25 (3):265-70. PMID: [http://pubmed.gov/14585453 14585453]</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" | [[Subarachnoid hemorrhage|Subarachnoid  hemorrhage]]<ref name="pmid14585453">Yeh ST, Lee WJ, Lin HJ, Chen CY, Te AL, Lin HJ (2003) [http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=14585453 Nonaneurysmal subarachnoid hemorrhage secondary to tuberculous meningitis: report of two cases.] ''J Emerg Med'' 25 (3):265-70. PMID: [http://pubmed.gov/14585453 14585453]</ref>
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px; text-align:center" |✔
| style="background: #F5F5F5; padding: 5px; text-align:center" |✔
| style="background: #F5F5F5; padding: 5px;" |Xanthochromia<ref name="pmid1198628">{{cite journal| author=Lee MC, Heaney LM, Jacobson RL, Klassen AC| title=Cerebrospinal fluid in cerebral hemorrhage and infarction. | journal=Stroke | year= 1975 | volume= 6 | issue= 6 | pages= 638-41 | pmid=1198628 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1198628  }}</ref>
| style="background: #F5F5F5; padding: 5px;" |[[Xanthochromic|Xanthochromia]]<ref name="pmid1198628">{{cite journal| author=Lee MC, Heaney LM, Jacobson RL, Klassen AC| title=Cerebrospinal fluid in cerebral hemorrhage and infarction. | journal=Stroke | year= 1975 | volume= 6 | issue= 6 | pages= 638-41 | pmid=1198628 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1198628  }}</ref>
| style="background: #F5F5F5; padding: 5px;" |CT scan without contrast<ref name="pmid21694755">{{cite journal| author=Birenbaum D, Bancroft LW, Felsberg GJ| title=Imaging in acute stroke. | journal=West J Emerg Med | year= 2011 | volume= 12 | issue= 1 | pages= 67-76 | pmid=21694755 | doi= | pmc=3088377 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21694755  }}</ref><ref name="pmid21807345">{{cite journal| author=DeLaPaz RL, Wippold FJ, Cornelius RS, Amin-Hanjani S, Angtuaco EJ, Broderick DF et al.| title=ACR Appropriateness Criteria® on cerebrovascular disease. | journal=J Am Coll Radiol | year= 2011 | volume= 8 | issue= 8 | pages= 532-8 | pmid=21807345 | doi=10.1016/j.jacr.2011.05.010 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21807345  }}</ref>
| style="background: #F5F5F5; padding: 5px;" |CT scan without contrast<ref name="pmid21694755">{{cite journal| author=Birenbaum D, Bancroft LW, Felsberg GJ| title=Imaging in acute stroke. | journal=West J Emerg Med | year= 2011 | volume= 12 | issue= 1 | pages= 67-76 | pmid=21694755 | doi= | pmc=3088377 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21694755  }}</ref><ref name="pmid21807345">{{cite journal| author=DeLaPaz RL, Wippold FJ, Cornelius RS, Amin-Hanjani S, Angtuaco EJ, Broderick DF et al.| title=ACR Appropriateness Criteria® on cerebrovascular disease. | journal=J Am Coll Radiol | year= 2011 | volume= 8 | issue= 8 | pages= 532-8 | pmid=21807345 | doi=10.1016/j.jacr.2011.05.010 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21807345  }}</ref>
| style="background: #F5F5F5; padding: 5px; text-align:center" |✔
| style="background: #F5F5F5; padding: 5px; text-align:center" |✔
| style="background: #F5F5F5; padding: 5px; text-align:center" |✔
| style="background: #F5F5F5; padding: 5px; text-align:center" |✔
Line 117: Line 384:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" | [[Stroke]]
| style="background: #DCDCDC; padding: 5px; text-align: center;" | [[Stroke]]
| style="background: #F5F5F5; padding: 5px; text-align:center" |
| style="background: #F5F5F5; padding: 5px; text-align:center" |✔
| style="background: #F5F5F5; padding: 5px; text-align:center" |✔
| style="background: #F5F5F5; padding: 5px; text-align:center" | Normal
| style="background: #F5F5F5; padding: 5px; text-align:center" | Normal
Line 133: Line 399:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Neurosyphilis]]<ref name="pmid22482824">{{cite journal| author=Liu LL, Zheng WH, Tong ML, Liu GL, Zhang HL, Fu ZG et al.| title=Ischemic stroke as a primary symptom of neurosyphilis among HIV-negative emergency patients. | journal=J Neurol Sci | year= 2012 | volume= 317 | issue= 1-2 | pages= 35-9 | pmid=22482824 | doi=10.1016/j.jns.2012.03.003 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22482824  }} </ref><ref name="pmid24365430">{{cite journal |vauthors=Berger JR, Dean D |title=Neurosyphilis |journal=Handb Clin Neurol |volume=121 |issue= |pages=1461–72 |year=2014 |pmid=24365430 |doi=10.1016/B978-0-7020-4088-7.00098-5 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Neurosyphilis]]<ref name="pmid22482824">{{cite journal| author=Liu LL, Zheng WH, Tong ML, Liu GL, Zhang HL, Fu ZG et al.| title=Ischemic stroke as a primary symptom of neurosyphilis among HIV-negative emergency patients. | journal=J Neurol Sci | year= 2012 | volume= 317 | issue= 1-2 | pages= 35-9 | pmid=22482824 | doi=10.1016/j.jns.2012.03.003 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22482824  }} </ref><ref name="pmid24365430">{{cite journal |vauthors=Berger JR, Dean D |title=Neurosyphilis |journal=Handb Clin Neurol |volume=121 |issue= |pages=1461–72 |year=2014 |pmid=24365430 |doi=10.1016/B978-0-7020-4088-7.00098-5 |url=}}</ref>
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px; text-align:center" |✔
| style="background: #F5F5F5; padding: 5px; text-align:center" |✔
| style="background: #F5F5F5; padding: 5px;" |'''↑''' [[Leukocytes]] and [[protein]]
| style="background: #F5F5F5; padding: 5px;" |'''↑''' [[Leukocytes]] and [[protein]]
| style="background: #F5F5F5; padding: 5px;" |CSF [[VDRL]]-specifc
| style="background: #F5F5F5; padding: 5px;" |CSF [[VDRL]]-specific
CSF FTA-Ab -sensitive<ref name="pmid22421697">{{cite journal| author=Ho EL, Marra CM| title=Treponemal tests for neurosyphilis--less accurate than what we thought? | journal=Sex Transm Dis | year= 2012 | volume= 39 | issue= 4 | pages= 298-9 | pmid=22421697 | doi=10.1097/OLQ.0b013e31824ee574 | pmc=3746559 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22421697  }}</ref>
CSF FTA-Ab -sensitive<ref name="pmid22421697">{{cite journal| author=Ho EL, Marra CM| title=Treponemal tests for neurosyphilis--less accurate than what we thought? | journal=Sex Transm Dis | year= 2012 | volume= 39 | issue= 4 | pages= 298-9 | pmid=22421697 | doi=10.1097/OLQ.0b013e31824ee574 | pmc=3746559 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22421697  }}</ref>
| style="background: #F5F5F5; padding: 5px; text-align:center" |✔
| style="background: #F5F5F5; padding: 5px; text-align:center" |✔
Line 152: Line 417:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Viral encephalitis]]
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Viral encephalitis]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |Increased [[RBC]]S or xanthochromia, [[Mononuclear cells|mononuclear]] [[lymphocytosis]], high protein content, normal [[glucose]]
| style="background: #F5F5F5; padding: 5px;" |Increased [[RBC]]S or xanthochromia, [[Mononuclear cells|mononuclear]] [[lymphocytosis]], high protein content, normal [[glucose]]
Line 164: Line 428:
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |Tick bite/mosquito bite/ viral prodome for several days
| style="background: #F5F5F5; padding: 5px;" |Tick bite/mosquito bite/ viral prodrome for several days
| style="background: #F5F5F5; padding: 5px;" |Extreme lethargy, rash [[hepatosplenomegaly]], [[lymphadenopathy]], [[behavioural]] changes
| style="background: #F5F5F5; padding: 5px;" |Extreme lethargy, rash [[hepatosplenomegaly]], [[lymphadenopathy]], [[behavioural|behavioral]] changes
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Herpes simplex encephalitis]]
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Herpes simplex encephalitis]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 183: Line 446:
| style="background: #F5F5F5; padding: 5px;" |[[Delirium]], cortical [[blindness]], [[cerebral edema]], [[seizure]]
| style="background: #F5F5F5; padding: 5px;" |[[Delirium]], cortical [[blindness]], [[cerebral edema]], [[seizure]]
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Wernicke’s encephalopathy
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Wernicke's encephalopathy|Wernicke’s encephalopathy]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |Normal
| style="background: #F5F5F5; padding: 5px;" |Normal
Line 196: Line 458:
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |History of alcohal abuse
| style="background: #F5F5F5; padding: 5px;" |History of alcohol abuse
| style="background: #F5F5F5; padding: 5px;" |[[Ophthalmoplegia]], [[confusion]]
| style="background: #F5F5F5; padding: 5px;" |[[Ophthalmoplegia]], [[confusion]]
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[CNS abscess]]
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[CNS abscess]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |'''↑''' [[leukocytes]] >100,000/ul, '''↓''' [[glucose]] and '''↑''' protien, '''↑''' red blood cells, [[lactic acid]] >500mg  
| style="background: #F5F5F5; padding: 5px;" |'''↑''' [[leukocytes]] >100,000/ul, '''↓''' [[glucose]], '''↑'''[[protein]], '''↑''' red blood cells, and [[lactic acid]] >500mg  
| style="background: #F5F5F5; padding: 5px;" |Contrast enhanced MRI is more sensitive and specific,
| style="background: #F5F5F5; padding: 5px;" |Contrast enhanced MRI is more sensitive and specific,
[[Histopathological]] examination of brain tissue
[[Histopathological]] examination of [[brain]] tissue
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
Line 214: Line 475:
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |History of [[drug abuse]], [[endocarditis]], '''↓''' [[immune]] status
| style="background: #F5F5F5; padding: 5px;" |History of [[drug abuse]], [[endocarditis]], '''↓''' [[immune]] status
| style="background: #F5F5F5; padding: 5px;" |High grade [[fever]], [[fatigue]],[[Nausea and vomiting|nausea]], [[vomiting]]
| style="background: #F5F5F5; padding: 5px;" |High-grade [[fever]], [[fatigue]], [[Nausea and vomiting|nausea]], [[vomiting]]
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Drug toxicity]]
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Drug toxicity]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 233: Line 493:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Conversion disorder]]  
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Conversion disorder]]  
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 249: Line 508:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Electrolyte disturbance]]
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Electrolyte disturbance]]
| style="background: #F5F5F5; padding: 5px; text-align:center" |'''↓''' or '''↑'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 265: Line 523:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Febrile convulsion]]
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Febrile convulsion]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px; text-align:center" |Not performed in first simple febrile [[seizures]]
| style="background: #F5F5F5; padding: 5px; text-align:center" |Not performed in first simple febrile [[seizures]]
Line 281: Line 538:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Subdural empyema]]
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Subdural empyema]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px; text-align:center" |✔
| style="background: #F5F5F5; padding: 5px; text-align:center" |✔
| style="background: #F5F5F5; padding: 5px; text-align:center" |
| style="background: #F5F5F5; padding: 5px; text-align:center" |
| style="background: #F5F5F5; padding: 5px;" |Clinical assesment and [[MRI]]  
| style="background: #F5F5F5; padding: 5px;" |Clinical assessment and [[MRI]]  
| style="background: #F5F5F5; padding: 5px; text-align:center" |✔
| style="background: #F5F5F5; padding: 5px; text-align:center" |✔
| style="background: #F5F5F5; padding: 5px; text-align:center" |✔
| style="background: #F5F5F5; padding: 5px; text-align:center" |✔
Line 295: Line 551:
| style="background: #F5F5F5; padding: 5px;" |History of relapses and remissions
| style="background: #F5F5F5; padding: 5px;" |History of relapses and remissions
| style="background: #F5F5F5; padding: 5px;" |Blurry vision, [[urinary incontinence]], [[fatigue]]
| style="background: #F5F5F5; padding: 5px;" |Blurry vision, [[urinary incontinence]], [[fatigue]]
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hypoglycemia]]
| style="background: #F5F5F5; padding: 5px; text-align:center" |↓ or '''↑'''
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |Serum blood [[Glucose-1-phosphate adenylyltransferase|glucose]]
[[HbA1c]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;text-align:center" |
| style="background: #F5F5F5; padding: 5px;text-align:center" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px; text-align:center" |  ✔
| style="background: #F5F5F5; padding: 5px; text-align:center" |
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |History of [[Diabetes mellitus|diabetes]]
| style="background: #F5F5F5; padding: 5px;" |[[Palpitation|Palpitations]], [[sweating]], [[dizziness]], low serum, [[glucose]]
|}
|}


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
[[Category:Needs overview]]
[[Category:Needs content]]
[[Category:Endocrinology]]
[[Category:Emergency medicine]]
[[Category:Primary care]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Latest revision as of 22:39, 25 February 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohammed Abdelwahed M.D[2]

Overview

Hypoglycemia should be differentiated from other causes of autonomic hyperactivity symptoms. Neonatal hypoglycemia should be differentiated from other causes of neurological symptoms in neonates such as sepsis, metabolic diseases: urea cycle disorders, and branched-chain organic acidemias, hyponatremia and neonatal asphyxia. In adults, hypoglycemia should be differentiated from other diseases that may cause autonomic hyperactivity symptoms, such as hyperthyroidism, anxiety, arrhythmia, and pheochromocytoma.

Differentiating Hypoglycemia from other Diseases

Differentiating Different Causes of Hypoglycemia from each other:

Fasting symptoms Postprandial symptoms Plasma insulin C-peptide proinsulin Sulfonylurea in plasma insulin or insulin receptor antibodies
Insulinoma + - high high high - -
Oral hypoglycemia agent-induced - - high high high + -
Autoimmune hypoglycemia - - high high high - +
NIPHS* - + high high high - -
Exogenous insulin - - high low low - -
Non-islet cell tumors - - low low low - -

*(NIPHS) non-insulinoma pancreatogenous hypoglycemia syndrome

Diagnoses Laboratory Findings differentiating among causes of Hypoglycemia
S.Glucose
(mg/dL)
C Peptide (pmol/L) S.Insulin (μU/mL) S.Proinsulin
(pmol/L)
S. Beta hydroxybutyrate Glucose increase after glucagon(mg/dL) Oral Hypoglycemic agent Antibodies to Insulin
Normal/Fasting <55 <200 <3 <5 >2.7 <25 - -
Exogenous Insulin <55 <200 >>3 <5 ≤2.7 >25 - -
Insulinoma <55 ≥200 ≥3 ≥5 ≤2.7 >25 - -
Nesidioblastosis
Post gastric bypass hypoglycemia (PGPH)
Insulin autoimmune hypoglycemia <55 >>200 >>3 >>5 ≤2.7 >25 - +
Oral hypoglycemic agent <55 ≥200 S. ≥5 ≤2.7 >25 + -
IGF¤ <55 <200 <3 <5 ≤2.7 >25 - -

‡ Free C-peptide and proinsulin concentrations are low
¤ IGF= Insulin Growth Factor, Increased pro-IGF-2, free IGF-2, IGF-2/IGF-1 ratio

Differentiating Hypoglycemia from other diseases that cause autonomic hyperactivity symptoms:

Disease Clinical Manifestation Investigations
Symptoms Signs
Palpitations Fever Sweating Headache
Hypoglycemia + - + +
Anxiety disorders + - + +
  • Rapid pulse and may be irregular
  • Psychiatry evaluation
Pheochromocytoma[2][3] + + + +
Arrhythmia + - - -
  • Irregular pulse
  • ECG changes according to the cause
Hyperthyroidism + + + +

Differentiating Hypoglycemia from other Diseases that Cause Neurological Symptoms in Neonates:

Disease History and symptoms Investigations
Family History Lethargy and irritability Improvement of symptoms with glucose intake Fever Hepatomegaly
Hypoglycemia + + + - -
  • Blood glucose level
Sepsis - + - + -
  • Blood cultures
Inborn errors of metabolism + + - - +
  • Positive blood tests
Hyponatremia - + - - -
  • Plasma sodium falls below 125 mEq/L
Perinatal asphyxia + + - - -
  • MRI of acute brain injury confirms the diagnosis of encephalopathy

Differentiating Hypoglycemia from other Diseases that Cause Coma and Consciousness Alterations:

Diseases Diagnostic tests Physical Examination Symptoms Past medical history Other Findings
CT /MRI CSF Findings Gold standard test Neck stiffness Motor or Sensory deficit Papilledema Bulging fontanelle Cranial nerves Headache Fever Altered mental status
Hypoglycemia Serum blood glucose

HbA1c

History of diabetes Palpitations, sweating, dizziness, low serum, glucose
Brain tumor[4][5] Cancer cells[6] MRI Cachexia, gradual progression of symptoms
Delirium tremens Clinical diagnosis Alcohol intake, sudden withdrawal or reduction in consumption Tachycardia, diaphoresis, hypertension, tremors, mydriasis, positional nystagmus,
Subarachnoid hemorrhage[7] Xanthochromia[8] CT scan without contrast[9][10] Trauma/fall Confusion, dizziness, nausea, vomiting
Stroke Normal CT scan without contrast TIAs, hypertension, diabetes mellitus Speech difficulty, gait abnormality
Neurosyphilis[11][12] Leukocytes and protein CSF VDRL-specific

CSF FTA-Ab -sensitive[13]

Unprotected sexual intercourse, STIs Blindness, confusion, depression,

Abnormal gait

Viral encephalitis Increased RBCS or xanthochromia, mononuclear lymphocytosis, high protein content, normal glucose Clinical assesment Tick bite/mosquito bite/ viral prodrome for several days Extreme lethargy, rash hepatosplenomegaly, lymphadenopathy, behavioral changes
Herpes simplex encephalitis Clinical assesment History of hypertension Delirium, cortical blindness, cerebral edema, seizure
Wernicke’s encephalopathy Normal History of alcohol abuse Ophthalmoplegia, confusion
CNS abscess leukocytes >100,000/ul, glucose, protein, red blood cells, and lactic acid >500mg Contrast enhanced MRI is more sensitive and specific,

Histopathological examination of brain tissue

History of drug abuse, endocarditis, immune status High-grade fever, fatigue, nausea, vomiting
Drug toxicity Lithium, Sedatives, phenytoin, carbamazepine
Conversion disorder Diagnosis of exclusion Tremors, blindness, difficulty swallowing
Electrolyte disturbance Depends on the cause Confusion, seizures
Febrile convulsion Not performed in first simple febrile seizures Clinical diagnosis and EEG Family history of febrile seizures, viral illness or gastroenteritis Age > 1 month,
Subdural empyema Clinical assessment and MRI History of relapses and remissions Blurry vision, urinary incontinence, fatigue

References

  1. Cryer PE, Axelrod L, Grossman AB, Heller SR, Montori VM, Seaquist ER; et al. (2009). "Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline". J Clin Endocrinol Metab. 94 (3): 709–28. doi:10.1210/jc.2008-1410. PMID 19088155.
  2. Lenders JW, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P; et al. (2002). "Biochemical diagnosis of pheochromocytoma: which test is best?". JAMA. 287 (11): 1427–34. PMID 11903030.
  3. Bravo EL (1991). "Pheochromocytoma: new concepts and future trends". Kidney Int. 40 (3): 544–56. PMID 1787652.
  4. Soffer D (1976) Brain tumors simulating purulent meningitis. Eur Neurol 14 (3):192-7. PMID: 1278192
  5. Weston CL, Glantz MJ, Connor JR (2011). "Detection of cancer cells in the cerebrospinal fluid: current methods and future directions". Fluids Barriers CNS. 8 (1): 14. doi:10.1186/2045-8118-8-14. PMC 3059292. PMID 21371327.
  6. Yeh ST, Lee WJ, Lin HJ, Chen CY, Te AL, Lin HJ (2003) Nonaneurysmal subarachnoid hemorrhage secondary to tuberculous meningitis: report of two cases. J Emerg Med 25 (3):265-70. PMID: 14585453
  7. Lee MC, Heaney LM, Jacobson RL, Klassen AC (1975). "Cerebrospinal fluid in cerebral hemorrhage and infarction". Stroke. 6 (6): 638–41. PMID 1198628.
  8. Birenbaum D, Bancroft LW, Felsberg GJ (2011). "Imaging in acute stroke". West J Emerg Med. 12 (1): 67–76. PMC 3088377. PMID 21694755.
  9. DeLaPaz RL, Wippold FJ, Cornelius RS, Amin-Hanjani S, Angtuaco EJ, Broderick DF; et al. (2011). "ACR Appropriateness Criteria® on cerebrovascular disease". J Am Coll Radiol. 8 (8): 532–8. doi:10.1016/j.jacr.2011.05.010. PMID 21807345.
  10. Liu LL, Zheng WH, Tong ML, Liu GL, Zhang HL, Fu ZG; et al. (2012). "Ischemic stroke as a primary symptom of neurosyphilis among HIV-negative emergency patients". J Neurol Sci. 317 (1–2): 35–9. doi:10.1016/j.jns.2012.03.003. PMID 22482824.
  11. Berger JR, Dean D (2014). "Neurosyphilis". Handb Clin Neurol. 121: 1461–72. doi:10.1016/B978-0-7020-4088-7.00098-5. PMID 24365430.
  12. Ho EL, Marra CM (2012). "Treponemal tests for neurosyphilis--less accurate than what we thought?". Sex Transm Dis. 39 (4): 298–9. doi:10.1097/OLQ.0b013e31824ee574. PMC 3746559. PMID 22421697.